Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Sidhar, Himakshi ^a   Giri, Ranjit K ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTHRACENE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; NERVE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIFITHRIN; PROTEIN P53; PYRAZOLANTHRONE; STRESS ACTIVATED PROTEIN KINASE; TOLUENE; WORTMANNIN;

ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NEUROBLASTOMA; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

ANDROSTADIENES; ANIMALS; ANTHRACENES; APOPTOSIS; BENZOTHIAZOLES; CELL LINE, TUMOR; CURCUMIN; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEUROBLASTOMA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TIME FACTORS; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85011272720     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41420     Document Type: Article

References (57)

1. Brossard, J., Bernstein, M. L. & Lemieux, B. Neuroblastoma: an enigmatic disease. Br Med Bull 52, 787-801 (1996).
2. Maris, J. M. Recent advances in neuroblastoma. N Engl J Med 362, 2202-2211 (2010).
3. Shimada, H. et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86, 364-372 (1999).
4. Weinstein, J. L., Katzenstein, H. M. & Cohn, S. L. Advances in the diagnosis and treatment of neuroblastoma. Oncologist 8, 278-292 (2003).
5. Bansal, D., Marwaha, R. K., Trehan, A., Rao, K. L. & Gupta, V. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than one year: a 15-years experience. Indian Pediatr 45, 135-139 (2008).
6. Brown, R. & Strathdee, G. Epigenomics and epigenetic therapy of cancer. Trends Mol Med 8, S43-48 (2002).
7. Johnstone, R. W., Ruefli, A. A. & Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164 (2002).
8. Alvarez, E., Zhou, W., Witta, S. E. & Freed, C. R. Characterization of the Bex gene family in humans, mice, and rats. Gene 357, 18-28 (2005).
9. Brown, A. L. & Kay, G. F. Bex1, a gene with increased expression in parthenogenetic embryos, is a member of a novel gene family on the mouse X chromosome. Hum Mol Genet 8, 611-619 (1999).
10. Fernandez, E. M., Diaz-Ceso, M. D. & Vilar, M. Brain expressed and X-linked (Bex) proteins are intrinsically disordered proteins (IDPs) and form new signaling hubs. PLoS One 10, e0117206 (2015).
11. Kazi, J. U., Kabir, N. N. & Ronnstrand, L. Brain-Expressed X-linked (BEX) proteins in human cancers. Biochim Biophys Acta 1856, 226-233 (2015).
12. Foltz, G. et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 66, 6665-6674 (2006).
13. Mukai, J., Suvant, P. & Sato, T. A. Nerve growth factor-dependent regulation of NADE-induced apoptosis. Vitam Horm 66, 385-402 (2003).
14. Tong, X., Xie, D., Roth, W., Reed, J. & Koeffler, H. P. NADE (p75NTR-associated cell death executor) suppresses cellular growth in vivo. Int J Oncol 22, 1357-1362 (2003).
15. Yu, Y. et al. Characterization of human dopamine responsive protein DRG-1 that binds to p75NTR-associated cell death executor NADE. Brain Res 1100, 13-20 (2006).
16. Anto, R. J., Mukhopadhyay, A., Denning, K. & Aggarwal, B. B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143-150 (2002).
17. Lin, Y. G. et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13, 3423-3430 (2007).
18. Jana, N. R., Dikshit, P., Goswami, A. & Nukina, N. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279, 11680-11685 (2004).
19. Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290 (2007).
20. Chang, H. Y. & Yang, X. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 64, 821-846 (2000).
21. Sharma, S. et al. A novel DNA intercalator, 8-methoxy pyrimido[4′, 5′ :4,5]thieno (2,3-b)quinoline-4(3H)-one induces apoptosis in cancer cells, inhibits the tumor progression and enhances lifespan in mice with tumor. Molecular carcinogenesis 52, 413-425 (2013).
22. Sahu, U. et al. A Novel Anticancer Agent, 8-Methoxypyrimido[4′, 5′ :4,5]thieno(2,3-) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and -Independent Apoptotic Pathways. PLoS One 8, e66430 (2013).
23. Komarov, P. G. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737 (1999).
24. Freudlsperger, C., Greten, J. & Schumacher, U. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB. Anticancer Res 28, 209-214 (2008).
25. Boatright, K. M. & Salvesen, G. S. Mechanisms of caspase activation. Curr Opin Cell Biol 15, 725-731 (2003).
26. Cartee, L. et al. Synergistic induction of apoptosis in human myeloid leukemia cells by phorbol 12-myristate 13-acetate and flavopiridol proceeds via activation of both the intrinsic and tumor necrosis factor-mediated extrinsic cell death pathways. Mol Pharmacol 61, 1313-1321 (2002).
27. Boulares, A. H. et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274, 22932-22940 (1999).
28. Sun, S. H., Huang, H. C., Huang, C. & Lin, J. K. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin. Eur J Pharmacol 690, 22-30 (2012).
29. Kang, S. K., Cha, S. H. & Jeon, H. G. Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev 15, 165-174 (2006).
30. Lindblad, O. et al. BEX1 acts as a tumor suppressor in acute myeloid leukemia. Oncotarget 6, 21385-21405 (2015).
31. Karakoula, K. et al. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma. Cancer Lett 346, 34-44 (2014).
32. Mukai, J. et al. Structure-function analysis of NADE: identification of regions that mediate nerve growth factor-induced apoptosis. J Biol Chem 277, 13973-13982 (2002).
33. Gao, W. et al. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma. J Exp Clin Cancer Res 35, 92 (2016).
34. Tanaka, M., Yamazaki, M. & Chiba, K. Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells. Biol Pharm Bull 32, 1220-1223 (2009).
35. Picone, P. et al. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation. Free Radic Res 48, 1397-1408 (2014).
36. Xiang, X. Y. et al. Inhibition of autophagic flux by ROS promotes apoptosis during DTT-induced ER/oxidative stress in HeLa cells. Oncol Rep 35, 3471-3479 (2016).
37. Tello Velasquez, J. et al. Low-dose curcumin stimulates proliferation, migration and phagocytic activity of olfactory ensheathing cells. PLoS One 9, e111787 (2014).
38. Thayyullathil, F., Chathoth, S., Hago, A., Patel, M. & Galadari, S. Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic Biol Med 45, 1403-1412 (2008).
39. Hartley, K. O. et al. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82, 849-856 (1995).
40. Sarkaria, J. N. et al. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 58, 4375-4382 (1998).
41. Khanna, K. K. et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 20, 398-400 (1998).
42. Shieh, S. Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334 (1997).
43. Shi, Y. et al. ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. Cell Death Differ 21, 612-623 (2014).
44. Choi, H. J., Kang, K. S., Fukui, M. & Zhu, B. T. Critical role of the JNK-p53-GADD45alpha apoptotic cascade in mediating oxidative cytotoxicity in hippocampal neurons. Br J Pharmacol 162, 175-192 (2010).
45. Lee, Y. S., Wan, J., Kim, B. J., Bae, M. A. & Song, B. J. Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen. J Pharmacol Exp Ther 317, 202-208 (2006).
46. Kuenzi, P., Kiefer, S., Koryakina, A. & Hamburger, M. Promotion of cell death or neurite outgrowth in PC-12 and N2a cells by the fungal alkaloid militarinone A depends on basal expression of p53. Apoptosis 13, 364-376 (2008).
47. el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W. & Vogelstein, B. Definition of a consensus binding site for p53. Nat Genet 1, 45-49 (1992).
48. Veprintsev, D. B. & Fersht, A. R. Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA. Nucleic acids research 36, 1589-1598 (2008).
49. Ostrakhovitch, E. A. & Cherian, M. G. Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: the lack of effect of ERK in p53 mediated copper induced apoptosis. J Cell Biochem 95, 1120-1134 (2005).
50. Schuler, M., Bossy-Wetzel, E., Goldstein, J. C., Fitzgerald, P. & Green, D. R. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275, 7337-7342 (2000).
51. Soengas, M. S. et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156-159 (1999).
52. Giri, R. K., Malhi, H., Joseph, B., Kandimalla, J. & Gupta, S. Metal-catalyzed oxidation of extracellular matrix components perturbs hepatocyte survival with activation of intracellular signaling pathways. Exp Cell Res 291, 451-462 (2003).
53. Ghate, P. S., Sidhar, H., Carlson, G. A. & Giri, R. K. Development of a novel cellular model of Alzheimer's disease utilizing neurosphere cultures derived from B6C3-Tg(APPswe, PSEN1dE9)85Dbo/J embryonic mouse brain. Springerplus 3, 161 (2014).
54. Giri, R. K. et al. Prion infection of mouse neurospheres. Proc Natl Acad Sci USA 103, 3875-3880 (2006).
55. Donze, O. & Picard, D. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic acids research 30, e46 (2002).
56. Giri, R. K., Selvaraj, S. K. & Kalra, V. K. Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol 170, 5281-5294 (2003).
57. Giri, R. K., Rajagopal, V., Shahi, S., Zlokovic, B. V. & Kalra, V. K. Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1. Am J Physiol Cell Physiol 289, C264-276 (2005).